The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeywords Studios Plc Regulatory News (KWS)

Share Price Information for Keywords Studios Plc (KWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,280.00
Bid: 1,277.00
Ask: 1,282.00
Change: -9.00 (-0.70%)
Spread: 5.00 (0.392%)
Open: 1,280.00
High: 1,312.00
Low: 1,258.00
Prev. Close: 1,289.00
KWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Sep 2023 07:00

RNS Number : 0221L
Keywords Studios PLC
01 September 2023
 

1 September 2023

Keywords Studios plc ("the Company")

 

Total Voting Rights

 

In accordance with DTR 5.6 of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTR"), the total number of ordinary shares of £0.01 each in the capital of the Company ("Ordinary Shares") in issue as at 31 August 2023 was 79,244,513 with each Ordinary Share carrying the right to one vote. The Company does not hold any shares in treasury.

There are 193,562 Ordinary Shares in the Company's Employee Benefit Trust ("EBT"), and the EBT has waived its right to exercise its voting rights and to receive dividends in respect of these Ordinary Shares.

Therefore, the number of Ordinary Shares with voting rights is 79,050,951. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Financial Conduct Authority's DTR.

 

For further information, please contact:

Investor Contacts:

 

Media Contacts:

Keywords Studios

Giles Blackham

Director of Investor Relations

+44 7714 134 681

gblackham@keywordsstudios.com

 

MHP Group

Katie Hunt / Eleni Menikou / Charles Hirst

+44 20 3128 8794

keywords@mhpgroup.com

 

Numis Securities

Stuart Skinner / Will Baunton

Nominated Adviser & Broker

+44 20 7260 1000

 

 

 

About Keywords Studios (www.keywordsstudios.com)

Keywords Studios is an international provider of creative and technology-enabled solutions to the global video games and entertainment industries. Established in 1998, and now with over 70 facilities in 26 countries strategically located in Asia, Australia, the Americas, and Europe, it provides services across the entire content development life cycle through its Create, Globalize and Engage service lines to a large blue-chip client base across the globe.

Keywords Studios has a strong market position, providing services to 24 of the top 25 most prominent games companies. Across the games and entertainment industry, clients include Activision Blizzard, Bandai Namco, Bethesda, Electronic Arts, Epic Games, Konami, Microsoft, Netflix, Riot Games, Square Enix, Supercell, TakeTwo, Tencent and Ubisoft. Recent titles worked on include Diablo IV, Hogwarts Legacy, Elden Ring, Fortnite, Valorant, League of Legends, Clash Royale and Doom Eternal. Keywords Studios is listed on AIM, the London Stock Exchange regulated market (KWS.L).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAKPFDLLDEFA
Date   Source Headline
14th Jun 20237:00 amRNSExtension of EBT Market Purchases to EUR15 million
12th Jun 20237:16 amRNSIssue of Shares
9th Jun 20237:00 amRNSDirector Share Purchase
8th Jun 20232:42 pmRNSHolding(s) in Company
1st Jun 20233:53 pmRNSTotal Voting Rights
26th May 20232:55 pmRNSResult of AGM
24th May 20234:06 pmRNSDirector/PDMR Shareholding
23rd May 20233:34 pmRNSIssue of Shares
23rd May 20231:45 pmRNSHolding(s) in Company
22nd May 20234:10 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSBlock listing return
15th May 20237:00 amRNSPassing of Ross Graham and Chairman Succession
11th May 20234:45 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAcquisition
9th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 20234:49 pmRNSTotal Voting Rights
18th Apr 20239:46 amRNSBlock Admission
17th Apr 20237:00 amRNSPublication of Annual Report and Accounts
3rd Apr 20239:59 amRNSTotal Voting Rights
3rd Apr 20238:56 amRNSIssue of Shares
31st Mar 202312:11 pmRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSAcquisition
15th Mar 20237:00 amRNSFinal Results
9th Mar 20233:32 pmRNSIssue of Shares
1st Mar 20234:56 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSTotal Voting Rights
13th Feb 20231:38 pmRNSIssue of Shares
1st Feb 20237:01 amRNSTotal Voting Rights
1st Feb 20237:00 amRNSAcquisition
25th Jan 20237:00 amRNSFull Year Trading Update
19th Jan 20237:00 amRNSDirectorate Change
16th Jan 20232:16 pmRNSHolding(s) in Company
12th Jan 202312:17 pmRNSIssue of Shares
3rd Jan 20237:00 amRNSTotal Voting Rights
16th Dec 20229:00 amRNSAcquisition
13th Dec 20227:00 amRNSAcquisition
9th Dec 20225:02 pmRNSDirector/PDMR Shareholding
8th Dec 20224:52 pmRNSDirector/PDMR Shareholding
7th Dec 202210:57 amRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition
1st Dec 20227:00 amRNSTotal Voting Rights
21st Nov 20223:00 pmRNSIssue of Shares
21st Nov 20227:00 amRNSTrading Update
14th Nov 20227:00 amRNSBlock Listing Return
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20222:30 pmRNSDirector/PDMR Shareholding
26th Oct 20227:00 amRNSAppointment of Chief Operating Officer Designate
21st Oct 20227:00 amRNSBlock Admission
19th Oct 20227:00 amRNSIssue of Shares
6th Oct 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.